|
Mumps-Immunglobulin
|
J06BB15 |
|
|
Palivizumab
|
J06BB16 |
|
|
Motavizumab
|
J06BB17 |
|
|
Raxibacumab
|
J06BB18 |
|
|
FSME-Immunglobulin
|
J06BB12 |
|
|
Pertussis-Immunglobulin
|
J06BB13 |
|
|
Condition_following_myocardial_infarction
|
Condition_following_myocardial_infarction |
|
|
skin_lesion
|
skin_lesion |
|
|
Masern-Immunglobulin
|
J06BB14 |
|
|
Immunoglobulin,_Subcutaneous
|
Immunoglobulin,_Subcutaneous |
|
|
Dialysis_out
|
Dialysis_out |
|
|
Liter_Per_Liter
|
Liter_Per_Liter |
|
|
Immunomodulatory_therapy_discontinued
|
Immunomodulatory_therapy_discontinued |
|
|
Model_name
|
Model_name |
|
|
high_dose_steroid_therapy
|
high_dose_steroid_therapy |
|
|
posaconazole
|
posaconazole |
|
|
Was_the_patient_enrolled_via_the_deferred_consent_process_for_non-consenting_patients?
|
Was_the_patient_enrolled_via_the_deferred_consent_process_for_non-consenting_patients? |
|
|
Moderate_dementia
|
Moderate_dementia |
|
|
site_of_drug_administration_specification
|
site_of_drug_administration_specification |
|
|
concept_key
|
concept_key |
|
